A US dietary supplement and ingredient provider that has said studies show its patented nicotinamide riboside ingredient may help treat COVID-19 apparently crossed regulatory lines when it posted that information on its social media pages.
ChromaDex Corp
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?